Harmonizing RCT-Duplicate Emulations In A Real World Replication Program (HARRP)

NCT06099067 · clinicaltrials.gov ↗

COMPLETED

Status

239990

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Canagliflozin
DRUG: DPP4 inhibitor
DRUG: Liraglutide
DRUG: Saxagliptin
DRUG: 2nd generation Sulfonylurea

Sponsor

AstraZeneca